Veiligheid en effectiviteit van plaatsing van een biologisch afbreekbare stent in de slokdarm tijdens chemoradiatie therapie.
- Conditions
- Dysphagia and malnutrition in patients with advanced esophageal cancer receiving neoadjuvant chemoradiatian therapy
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 16
Inclusion Criteria
1. T1-3N0-1M0 esophageal carcinoma;
2. Scheduled for neoadjuvant chemoradiation therapy prior to esophagectomy;
Exclusion Criteria
1. Tumor length > 10 cm;
2. Tumor growth within 5 cm of the upper esophageal sphincter;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety defined as the absence of a stent-procedure- or stent-related major complication.
- Secondary Outcome Measures
Name Time Method